EPTIS
BAM Logo

Immunohistochemistry Breast Markers Audit

EPTIS factsheet 587130 | Last revision 2019-06-18 | URL: https://www.eptis.bam.de/pts587130 https://www.eptis.bam.de/pts587130

PT provider
PT provider RCPAQAP RCPAQAP
Based in Australia
Language(s) English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Breast marker audit of cases reported Quality Assurance activity for laboratories reporting immunohistochemistry(IHC) and in-situ hybridisation (ISH) breast markers through an audit of clinical results. -
-
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by Yes on the basis of Accredited by NATA on the basis of ISO/IEC 17043:2010

Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (100 cases submitted per survey/1 survey per year)
Year of first operation
Contact details of the PT provider
Provider Contact person
RCPAQAP
Suite 201/8 Herbert Street
St Leonards, 2065
Australia

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Megan Cooke
Phone: (61 2) 9045 6012
Fax: (61 2) 9356 2003
Email: megan.cooke@rcpaqap.com.au megan.cooke@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminata Antin. Ms Luminata Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21